|
Volumn 30, Issue 12, 2003, Pages 1933-1940
|
Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
GASTRECTOMY;
HUMAN;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MALE;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
STOMACH TUMOR;
SURVIVAL RATE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
GASTRECTOMY;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
OXONIC ACID;
PYRIDINES;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TEGAFUR;
|
EID: 0642303137
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|